Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Swiss Stem Cells Biotech operates a FACT‑NetCord–accredited, GMP‑certified private/hybrid biobank in Switzerland that has stored over 26,000 samples, has released family cord blood units and >400 mesenchymal stem cell preparations (SVF) for clinical use, and functions as an ATMP‑grade manufacturing and storage facility for cord blood, cord tissue, placental tissue, adipose‑derived stem cells, and immune cells.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Swiss Stem Cells Biotech.